logo

CSTL

Castle Biosciences·NASDAQ
--
--(--)
--
--(--)
4.54 / 10
Netural

Analyst sentiment is overwhelmingly bullish—both of the two active analysts rate the stock ‘Strong Buy’—yet their historical win rates are modest (0.0% for Lake Street; 50.0% for Guggenheim). Fund-flow data echo a more positive tone: the medium-size bucket shows a 0.5021 inflow ratio with a positive trend, while overall and block flows lean slightly negative. This divergence suggests institutional caution but retail or mid-cap accumulation. In short, the street is optimistic, but capital movements hint at selective conviction.

FundamentalSentiment(4.54)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-26
InstitutionGuggenheim
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for CSTL?
  • CSTL holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.54/10 (Netural).